Arcus Biosciences (RCUS) Form 144: Brokered notice for RSU sales via Merrill Lynch

Rhea-AI Filing Summary

Arcus Biosciences Inc. submitted a Form 144 notice for proposed sales of Common Stock through Merrill Lynch (address shown). The filing lists Restricted Stock Units dated 12/15/2024 (7,307 shares) and 12/15/2022 (456 shares) as securities referenced in the form. The filing shows a numeric header entry of 198965.69 and 125,773,162 alongside an exchange label NYSE dated 05/11/2026.

Insights

Corporate Governance Analyst

Form 144 lists proposed brokerage sale of common shares tied to RSUs.

The filing records brokerage placement with Merrill Lynch and enumerates Restricted Stock Units of 7,307 and 456 shares with grant/vesting dates shown. The form header includes numeric lines (198965.69, 125,773,162) and an exchange label NYSE.

Timing and exact sale amounts tied to the Form 144 instructions are implied by the notice; final sale execution, pricing, and proceeds are not stated in the provided excerpt, and subsequent transaction reports would show completed trades.

Key Figures

RSU (12/15/2024): 7,307 shares RSU (12/15/2022): 456 shares Header numeric field: 198,965.69 +2 more

5 metrics

RSU (12/15/2024) 7,307 shares Restricted Stock Unit dated 12/15/2024 listed in the filing

RSU (12/15/2022) 456 shares Restricted Stock Unit dated 12/15/2022 listed in the filing

Header numeric field 198,965.69 Numeric entry shown in the filing header area

Header numeric field 125,773,162 Numeric entry shown in the filing header area

Form date / exchange 05/11/2026 / NYSE Date and exchange label shown in the filing header

Key Terms

Restricted Stock Unit, Form 144, Securities To Be Sold

3 terms

Restricted Stock Unit financial

"Restricted Stock Unit | Arcus Biosciences Inc. | 7,307 | 12/15/2024"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Securities To Be Sold regulatory

"144: Securities To Be Sold | Common | 12/15/2024"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California St Ste 1800 San Francisco CA 94104	7763	198965.69	125773162	05/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2024	Restricted Stock Unit	Arcus Biosciences Inc.			7307	12/15/2024	Equity Compensation
Common	12/15/2022	Restricted Stock Unit	Arcus Biosciences Inc.			456	12/15/2022	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arcus Biosciences (RCUS) Form 144 mean?

It notifies the SEC of an intended sale of restricted or control shares via a broker. The filing lists brokerage details and specific Restricted Stock Units of 7,307 and 456 shares with grant dates shown.

Does the Form 144 for RCUS mean the shares have already been sold?

No. A Form 144 is a notice of proposed sale, not proof of completion. The excerpt lists securities and brokerage details; executed trades would appear later in trade confirmations or subsequent filings.

Which securities are referenced in the RCUS filing?

The document references Common Stock and two Restricted Stock Units: 7,307 shares dated 12/15/2024 and 456 shares dated 12/15/2022, and shows Merrill Lynch as the broker.

Who is the broker listed on the Form 144 for RCUS?

The filing names Merrill Lynch with an address at 555 California St Ste 1800, San Francisco CA 94104 as the broker-dealer shown in the notice for the proposed sale.